An important pathological feature of Alzheimer's disease (AD) is the presence of extracellular senile plaques in the brain. Senile plaques are composed of aggregations of small peptides called -amyloid (A). Multiple lines of evidence demonstrate that overproduction/aggregation of A in the brain is a primary cause of AD and inhibition of A generation has become a hot topic in AD research. A is generated from -amyloid precursor protein (APP) through sequential cleavages first by -secretase and then by -secretase complex. Alternatively, APP can be cleaved by -secretase within the A domain to release soluble APP and preclude A generation. Cleavage of APP by caspases may also contribute to AD pathologies. Therefore, understanding the metabolism/processing of APP is crucial for AD therapeutics. Here we review current knowledge of APP processing regulation as well as the patho/physiological functions of APP and its metabolites. © 2011 Zhang et al; licensee BioMed Central Ltd.
CITATION STYLE
Zhang, Y. W., Thompson, R., Zhang, H., & Xu, H. (2011). APP processing in Alzheimer’s disease. Molecular Brain. https://doi.org/10.1186/1756-6606-4-3
Mendeley helps you to discover research relevant for your work.